Advances in the Oral Administration of Somatostatin Receptor Ligands in Acromegaly: A Systematic Review Focusing on Biochemical Response
Recent advances in pharmaceutical technology, aimed at overcoming poor drug permeation across the intestinal–epithelial membrane and the challenges posed by the acidic gastrointestinal environment, have led to the development of orally administered somatostatin receptor ligands (SRLs). This developm...
        Saved in:
      
    
          | Main Authors: | Clémence Reverdiau, Damien Denimal | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | MDPI AG
    
        2024-10-01 | 
| Series: | Pharmaceutics | 
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/16/11/1357 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients        
                          
 by: Mehmet Muhittin Yalçın, et al.
 Published: (2024-10-01)
- 
                
                    Insulinoma with suspected mutant somatostatin receptor expression according to histological examination        
                          
 by: Shunichiro Onish, et al.
 Published: (2024-11-01)
- 
                
                    Clinical and biochemical characteristics of patients with acromegaly and normal or increased prolactin levels        
                          
 by: Yuliya A. Kukushkina, et al.
 Published: (2024-12-01)
- 
                
                    Nursing Care of Patient with Acromegaly Disease — Case Report        
                          
 by: Seçil Erden Melikoğlu, et al.
 Published: (2019-06-01)
- 
                
                    Acromegaly: Is earlier diagnosis possible? Exploration of a screening algorithm to select high-risk patients        
                          
 by: Tessa N.A. Slagboom, et al.
 Published: (2025-03-01)
 
       